News | February 01, 2023
Sun Pharma Q3 FY23 Gross Sales up 13.1%; Net profit up 5.2%
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
Diagnostic imaging will become an increasingly vital process in healthcare
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
Zidavi is recommended by the Infectious Disease Society of America
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The company has reported total income of Rs. 78.50 crores during the period ended December 31, 2022
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
The company has reported total income of Rs. 211.36 crores during the period ended December 31, 2022
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
Subscribe To Our Newsletter & Stay Updated
